Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acolytin vs Huachansu in advanced hepatocellular carcinoma
CTR20170667Phase 3Completed
- Sponsor
- Shenogen Pharma Group
- Start
- Aug 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Icaritin in hepatocellular carcinoma (HCC), sponsored by Shenogen Pharma Group. Started Aug 2017; status: completed.
02
Drugs
Icaritin
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on CTR20170667.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20170667.